DCGI approves Phase II+III trials of Oxford University vaccine by Serum Institute, Pune
New Delhi, The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine …
DCGI approves Phase II+III trials of Oxford University vaccine by Serum Institute, Pune Read More